HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Glycogen Storage Disease XIII

mutation in ENO3

Also Known As:

Enolase 3 Deficiency; Enolase-Beta Deficiency; GSD XIII; GSD13

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Inborn Errors Metabolism: 1162
    - Inborn Errors Carbohydrate Metabolism
      - Glycogen Storage Disease: 1461
        Glycogen Storage Disease XIII: 1
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10142
  - Inborn Errors Metabolism: 1162
    - Inborn Errors Carbohydrate Metabolism
      - Glycogen Storage Disease: 1461
        Glycogen Storage Disease XIII: 1

Related Diseases

1.	Glycogen Storage Disease Type VII (Tarui's Disease)
2.	Dimauro disease

Experts

1.	Papazian, Óscar: 1 article (09/2013)
2.	Rivas-Chacón, Rafael: 1 article (09/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Glycogen Storage Disease XIII:

1.	PhosphofructokinasesIBA 09/06/2013 - "The conditions in the first group in order of decreasing frequency are the deficiencies of myophosforilase (GSD V), muscle phosphofructokinase (GSD VII), phosphoglycerate mutase 1 (GSD X) and beta enolase (GSD XIII). "
2.	Phosphopyruvate Hydratase (Enolase)IBA 09/06/2013 - "The conditions in the first group in order of decreasing frequency are the deficiencies of myophosforilase (GSD V), muscle phosphofructokinase (GSD VII), phosphoglycerate mutase 1 (GSD X) and beta enolase (GSD XIII). "
3.	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 09/06/2013 - "The conditions in the first group in order of decreasing frequency are the deficiencies of myophosforilase (GSD V), muscle phosphofructokinase (GSD VII), phosphoglycerate mutase 1 (GSD X) and beta enolase (GSD XIII). "